Subscribe
Friday, September 11, 2026
30 C
Bengaluru
type here...
Subscribe
Featured ArticleIndian Pharma Market ReportsThe Pharma Executive
3 min.Read

Hype and Happening: GLP-1 Growth Story – Follow the Patient, not the Primary Sales

Anup Soans
By Anup Soans

Is Obesity (Drugs) Masking Underlying (Metabolic) Risk Factors in Indian Pharma? Executive Summary The Indian Pharmaceutical Market (IPM) entered 2026 with strong momentum, delivering approximately 11% year-on-year growth in February 2026. The narrative appears compelling: chronic therapies are expanding, volumes are stabilizing, and GLP-1 agonists are positioning India within the global specialty drug landscape. However,…

Free Membership Required

You must be a Free member to access this content.

Join Now

Already a member? Log in here

Hot this week

Digital in Pharma

The Great Healthcare Pivot: Who Owns The Consumer Before They Become A Patient?

0
How wearables, diagnostics, AI and continuous monitoring are moving...
Featured Article

RPG-Raghava and Lessons From a Decade of Indian Pharma M&A

0
RPG Active Pharma’s agreement to acquire the API and...
Healthcare Ececutive

Pharmacy of the World Pricing Paradox

0
India occupies an extraordinary position in global pharmaceuticals. It...
Featured Article

Why The Government Must Stop Playing Market Trader And Start Being The Sheriff

0
India has two very different pharmaceutical regulators living inside...
MedicinMan Pharma Pulse

MedicinMan Pharma Pulse: August 2026

0
🚀 The Mega-Merger That Wasn't Early August saw the...

Topics

Digital in Pharma

The Great Healthcare Pivot: Who Owns The Consumer Before They Become A Patient?

0
How wearables, diagnostics, AI and continuous monitoring are moving...
Featured Article

RPG-Raghava and Lessons From a Decade of Indian Pharma M&A

0
RPG Active Pharma’s agreement to acquire the API and...
Healthcare Ececutive

Pharmacy of the World Pricing Paradox

0
India occupies an extraordinary position in global pharmaceuticals. It...
Featured Article

Why The Government Must Stop Playing Market Trader And Start Being The Sheriff

0
India has two very different pharmaceutical regulators living inside...
MedicinMan Pharma Pulse

MedicinMan Pharma Pulse: August 2026

0
🚀 The Mega-Merger That Wasn't Early August saw the...
Featured Article

GLP-1: When the Molecule Becomes a Commodity, What Becomes the Moat?

0
STOP PRESS August 10, 2026: Regulatory Authorisation — The UK...
Exclusive Report

How To See Dr Reddy’s Nestle In The Wellness Shift

0
GLP-1 medicines such as semaglutide and tirzepatide are changing...
The Pharma Executive

How To Power The India Biopharma Regulatory Revolution Now

0
Beyond the Pharmacy of the World: Why India's Biopharma...
spot_img

Related Articles

spot_imgspot_img
Previous article
Trump’s 100% Drug Tariffs Explained: The Surprising Opportunity for India
Next article
Sachhin Misshra has been elevated to the role of President at Akumentis Healthcare.

MedicinMan was launched in 2011 as India’s 1st Magazine dedicated to the cause of Field Force Excellence in Pharma and Devices.
Read More

Company

Headlines

The Great Healthcare Pivot: Who Owns The Consumer Before They Become A Patient?

0
How wearables, diagnostics, AI and continuous monitoring are moving...

RPG-Raghava and Lessons From a Decade of Indian Pharma M&A

0
RPG Active Pharma’s agreement to acquire the API and...

Pharmacy of the World Pricing Paradox

0
India occupies an extraordinary position in global pharmaceuticals. It...

Why The Government Must Stop Playing Market Trader And Start Being The Sheriff

0
India has two very different pharmaceutical regulators living inside...

Newsletter

Get important news delivered directly to your inbox and stay connected!

Copyright © 2026 | Crafted by SlamDunk